Adverse events due to drug consumption can damage the physical and mental wellbeing of patients and are a huge economic burden for the healthcare system (Sultana et al., 2013).
Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other signals for its products, including COVID-19 vaccine Comirnaty, almost i
German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data to ArisGlobal, which provides cloud software to
A review of side effects reported with coronavirus vaccines by the EMA's safety committee has uncovered cases of inflammation of the heart in people receiving the Pfizer/BioNTech Comirnaty
The head of the EMA has reiterated that there is no evidence to limit the use of AstraZeneca's COVID-19 vaccine in any age group, after Germany and Canada imposed restrictions in younger pa
Biogen has scaled back its ambitions for Denali-partnered Parkinson’s disease candidate BIIB122, abandoning a complex and likely costly phase 3 trial that isn’t due to com
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas